 Home > Active Ingredient News > Drugs Articles > Hebo Pharma's new-generation anti-CTLA-4 antibody HBM4003 was approved for two clinical trials in China

Hebo Pharma's new-generation anti-CTLA-4 antibody HBM4003 was approved for two clinical trials in China

 Last Update: 2021-09-19
 Source: Internet
 Author: User

Tags

china 1 sevierville

tea time food

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Hebo Pharmaceutical recently announced that the National Medical Products Administration (NMPA) of China approved its new generation of HBM4003 anti-CTLA-4 fully human monoclonal heavy chain antibody and PD-1 antibody for the treatment of advanced hepatocellular carcinoma (HCC) and other solid tumors Clinical trial application for patients, and clinical trial application for HBM4003 and PD-1 antibody combined treatment of advanced neuroendocrine tumor/carcinoma (NET/NEC) and other solid tumor patients
.

Prior to this, Hebo Medicine has obtained IND approval from the National Medical Products Administration (NMPA), the U.
S.
Food and Drug Administration (FDA) and the Australian Institutional Review Board (IRB) to carry out clinical trials, and to promote HBM4003 globally in an orderly manner.
Multiple clinical trials of monotherapy and combination therapy
.

Dr.
Wang Jinsong, Founder, Chairman and CEO of Hebo Medicine, said: "HBM4003 is a new generation of anti-CTLA-4 antibody.
Based on its unique mechanism of action, it has shown good safety and powerful anti-tumor effects in clinical studies.
Active
.
The approval of clinical trials for the two indications at the same time is another recognition of HBM4003, and it also makes us feel the responsibility and mission

on our shoulders .

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Top Product

$49-62/KG FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

Hot Sale 1-Adamantanamine Hydrochloride /1-Adamantanamine HCl CAS 665-66-7

CAS No.: 665-66-7

Pharmacy Grade

$20-25/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.